A multinational , randomized , open-label trial that compared insulin lispro low mixture ( LM@ ; n = @ ) twice daily with a basal-prandial regimen of insulin glargine once daily and insulin lispro once daily ( IGL ; n = @ ) over @ weeks in patients with HbA@c @-@ @ % and fasting plasma glucose @ mmol/l .